BOTHELL, Wash., June 5 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. will be presenting at the Needham & Company Biotechnology and Medical Technology Conference on Wednesday, June 14, 2006 at 9:30 a.m. Eastern Time at The New York Palace Hotel in New York City. Steven C. Quay, M.D., Ph.D., Chairman, President and CEO of Nastech, will provide a corporate overview, including a review of the Company’s product development programs.
To access the live audio webcast for this conference, please log on to Nastech’s website at http://www.nastech.com approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available following the event.
About Nastech
Nastech is a pharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. Nastech and its collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, diabetes, respiratory disease and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.
CONTACTS: Nastech Ed Bell Senior Investor Relations Manager (425) 908-3639 ir@nastech.com Noonan Russo Matthew Haines (Investors/Media) (212) 845-4235
Nastech Pharmaceutical Company Inc.
CONTACT: Ed Bell, Senior Investor Relations Manager of Nastech,+1-425-908-3639, ir@nastech.com; Investors-Media, Matthew Haines of NoonanRusso, +1-212-845-4235
Web site: http://www.nastech.com/
